Michel Vounatsos is CEO at Biogen and has served in this position and as a member of the Board of Directors since January 2017. Prior to that, from April 2016 until his appointment as our Chief Executive Officer, he served as Executive Vice President, Chief Commercial Officer. Prior to joining Biogen, Mr. Vounatsos spent 20 years at Merck & Co., Inc., a pharmaceutical company.

Share it on Social Media